BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25565510)

  • 21. Policy initiatives, culture and the prevention and control of chronic non-communicable diseases (NCDs) in the Caribbean.
    Samuels TA; Guell C; Legetic B; Unwin N
    Ethn Health; 2012; 17(6):631-49. PubMed ID: 23249261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Non-communicable chronic diseases in Brazil: from risk factors to social impact].
    Lessa I; Mendonça GA; Teixeira MT
    Bol Oficina Sanit Panam; 1996 May; 120(5):389-413. PubMed ID: 8924219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and prevention of cardiovascular disease and diabetes mellitus.
    Balakumar P; Maung-U K; Jagadeesh G
    Pharmacol Res; 2016 Nov; 113(Pt A):600-609. PubMed ID: 27697647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Columbus effect: the donor community's "discovery" of non communicable diseases.
    Norris J; Marano K
    World Hosp Health Serv; 2011; 47(2):4-7. PubMed ID: 22073874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urbanization and non-communicable disease in Southeast Asia: a review of current evidence.
    Angkurawaranon C; Jiraporncharoen W; Chenthanakij B; Doyle P; Nitsch D
    Public Health; 2014 Oct; 128(10):886-95. PubMed ID: 25369353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The road to the United Nations High Level Meeting on chronic non-communicable diseases.
    Hassell T; Hennis A
    West Indian Med J; 2011 Jul; 60(4):384-6. PubMed ID: 22097667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In the shadow of HIV/AIDS: forgotten diseases in sub-Saharan Africa: global health issues and funding agency responsibilities.
    Lemoine M; Girard PM; Thursz M; Raguin G
    J Public Health Policy; 2012 Nov; 33(4):430-8. PubMed ID: 22895470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of disability among people with cancer, cardiovascular disease, chronic respiratory disease and/or diabetes: a systematic review.
    Lisy K; Campbell JM; Tufanaru C; Moola S; Lockwood C
    Int J Evid Based Healthc; 2018 Sep; 16(3):154-166. PubMed ID: 29608458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-communicable diseases and health systems reform in low-and-middle-income countries.
    Robinson HM; Hort K
    Pac Health Dialog; 2012 Apr; 18(1):179-90. PubMed ID: 23240355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UN resolution on the prevention and control of non-communicable diseases: an opportunity for global action.
    Mamudu HM; Yang JS; Novotny TE
    Glob Public Health; 2011; 6(4):347-53. PubMed ID: 21607893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why Is Creating a Healthy Food Environment So Crucial to Making Improvements in Diet-Related NCDs?
    Hayashi F; Takemi Y
    J Nutr Sci Vitaminol (Tokyo); 2015; 61 Suppl():S36-8. PubMed ID: 26598879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-communicable diseases in South Asia: contemporary perspectives.
    Siegel KR; Patel SA; Ali MK
    Br Med Bull; 2014 Sep; 111(1):31-44. PubMed ID: 25190759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The contribution of specific non-communicable diseases to the achievement of the Sustainable Development Goal 3.4 in Peru.
    Carrillo-Larco RM; Bennett JE; Di Cesare M; Gregg EW; Bernabe-Ortiz A
    PLoS One; 2020; 15(10):e0240494. PubMed ID: 33045034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic diseases: the silent global epidemic.
    Meetoo D
    Br J Nurs; 2008 Nov 27-Dec 10; 17(21):1320-5. PubMed ID: 19060813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The burden of disease among the global poor.
    Gwatkin DR; Guillot M; Heuveline P
    Lancet; 1999 Aug; 354(9178):586-9. PubMed ID: 10470717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-communicable Diseases.
    Suzuki M; Webb D; Small R
    Int J Health Policy Manag; 2022 Jul; 11(7):1078-1089. PubMed ID: 33619925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The global epidemic of noncommunicable disease: the role of early-life factors.
    Singhal A
    Nestle Nutr Inst Workshop Ser; 2014; 78():123-32. PubMed ID: 24504213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional and global impacts of the 2007 Port-of-Spain Declaration on noncommunicable diseases.
    Kirton J; Knight WA; Hospedales CJ; Hippolyte D; Kulik J
    Rev Panam Salud Publica; 2018; 42():e194. PubMed ID: 31093221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "A Promise Unfulfilled": Stakeholder Influence and the 2018 UN High-Level Meeting on NCDs Comment on "Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-communicable Diseases".
    Ralston J
    Int J Health Policy Manag; 2022 Jul; 11(7):1225-1227. PubMed ID: 34814669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noncommunicable diseases among the Bahraini population: a review.
    Hamadeh RR
    East Mediterr Health J; 2000; 6(5-6):1091-7. PubMed ID: 12197332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.